Testing effectiveness (Phase 2)Study completedNCT02038907
What this trial is testing
Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP Vaccine
Who this might be right for
Healthy VolunteersNorovirus, Prevention
Takeda 420
Showing 6 of 6 results